心脏生物酶在预测2019冠状病毒病心血管结局中的应用
Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2.
作者信息
Gulmez Ali Osman, Aydin Sonay
机构信息
Department of Radiology, Erzincan University, Erzincan 24100, Turkey.
出版信息
World J Virol. 2023 Mar 25;12(2):132-135. doi: 10.5501/wjv.v12.i2.132.
Abstract
The relationship between coronavirus disease-19 (COVID-19) and cardiovascular diseases has been an important issue. Therefore, cardiac biomarkers and cardiac imaging have an important place in the diagnostic phase. It is important to know the relationship of biomarkers in COVID-19 so that we can understand the diagnosis of the disease, the predicted course and results after diagnosis.
摘要
冠状病毒病-19（COVID-19）与心血管疾病之间的关系一直是一个重要问题。因此，心脏生物标志物和心脏成像在诊断阶段具有重要地位。了解COVID-19中生物标志物的关系非常重要，这样我们才能理解该疾病的诊断、预测病程以及诊断后的结果。
相似文献
1
Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2.心脏生物酶在预测2019冠状病毒病心血管结局中的应用
World J Virol. 2023 Mar 25;12(2):132-135. doi: 10.5501/wjv.v12.i2.132.
2
Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2.心脏生物酶在预测2019冠状病毒病心血管结局中的作用
World J Virol. 2022 Sep 25;11(5):375-390. doi: 10.5501/wjv.v11.i5.375.
3
Comparative diagnostic yield and 3-month outcomes of "triple rule-out" and standard protocol coronary CT angiography in the evaluation of acute chest pain.比较“三联征”和标准方案冠状动脉 CT 血管造影在急性胸痛评估中的诊断效能和 3 个月结局。
J Cardiovasc Comput Tomogr. 2011 May-Jun;5(3):165-71. doi: 10.1016/j.jcct.2011.03.008. Epub 2011 Mar 16.
4
Prior SARS-CoV-2 Infection Is Associated With Coronary Vasomotor Dysfunction as Assessed by Coronary Flow Reserve From Cardiac Positron Emission Tomography.先前的 SARS-CoV-2 感染与冠状动脉血流储备（通过心脏正电子发射断层扫描评估）相关的冠状动脉血管运动功能障碍有关。
J Am Heart Assoc. 2022 Oct 18;11(20):e025844. doi: 10.1161/JAHA.122.025844. Epub 2022 Oct 17.
5
The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19.COVID-19 中的心血管疾病与预后性心生物标志物。
Mol Biol Rep. 2021 Feb;48(2):1763-1771. doi: 10.1007/s11033-021-06148-9. Epub 2021 Jan 22.
6
Role of the coronary and non-coronary cardiovascular findings on non-cardiac gated thoracic CT in predicting mortality in SARS-CoV-2 infection.非心脏门控胸部 CT 的冠状动脉和非冠状动脉心血管表现对 SARS-CoV-2 感染患者死亡率的预测作用。
Clin Imaging. 2022 Sep;89:49-54. doi: 10.1016/j.clinimag.2022.06.002. Epub 2022 Jun 9.
7
Cardiac Biomarker Abnormalities Are Closely Related to Prognosis in Patients with COVID-19.心脏生物标志物异常与 COVID-19 患者的预后密切相关。
Int Heart J. 2021;62(1):148-152. doi: 10.1536/ihj.20-180.
8
SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes.新型冠状病毒 2 型在年轻竞技运动员心脏中的作用。
Circulation. 2021 Jul 27;144(4):256-266. doi: 10.1161/CIRCULATIONAHA.121.054824. Epub 2021 Apr 17.
9
Alterations in Circulating miRNA Levels after Infection with SARS-CoV-2 Could Contribute to the Development of Cardiovascular Diseases: What We Know So Far.感染 SARS-CoV-2 后循环 miRNA 水平的改变可能导致心血管疾病的发生：目前我们所了解的情况。
Int J Mol Sci. 2023 Jan 25;24(3):2380. doi: 10.3390/ijms24032380.
10
Diagnostic value and key features of computed tomography in Coronavirus Disease 2019.计算机断层扫描在 2019 年冠状病毒病中的诊断价值和关键特征。
Emerg Microbes Infect. 2020 Dec;9(1):787-793. doi: 10.1080/22221751.2020.1750307.
本文引用的文献
1
The value of dual-energy computed tomography in the evaluation of myocarditis.双能 CT 在心肌炎评估中的价值。
Diagn Interv Radiol. 2023 Mar 29;29(2):276-282. doi: 10.5152/dir.2022.21749. Epub 2023 Jan 27.
2
Utility of cardiac bioenzymes in predicting cardiovascular outcomes in SARS-CoV-2.心脏生物酶在预测2019冠状病毒病心血管结局中的作用
World J Virol. 2022 Sep 25;11(5):375-390. doi: 10.5501/wjv.v11.i5.375.
3
Triple rule-out computed tomography angiography: Evaluation of acute chest pain in COVID-19 patients in the emergency department.三联排除计算机断层血管造影：急诊科对COVID-19患者急性胸痛的评估
World J Radiol. 2022 Aug 28;14(8):311-318. doi: 10.4329/wjr.v14.i8.311.
4
Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.凝血功能障碍、肝功能障碍与 COVID-19：发现一种有趣的关系。
World J Gastroenterol. 2022 Mar 21;28(11):1102-1112. doi: 10.3748/wjg.v28.i11.1102.
5
Computed tomography at every step: Long coronavirus disease.每一步都进行计算机断层扫描：长冠状病毒病。
Respir Investig. 2021 Sep;59(5):622-627. doi: 10.1016/j.resinv.2021.05.014. Epub 2021 Jun 29.
6
Cardiac Troponin-I and COVID-19: A Prognostic Tool for In-Hospital Mortality.心肌肌钙蛋白I与2019冠状病毒病：院内死亡率的预后评估工具
Cardiol Res. 2020 Dec;11(6):398-404. doi: 10.14740/cr1159. Epub 2020 Oct 23.
7
Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection.COVID-19 感染住院患者心肌损伤的患病率和影响。
J Am Coll Cardiol. 2020 Aug 4;76(5):533-546. doi: 10.1016/j.jacc.2020.06.007. Epub 2020 Jun 8.
8
Atrial and brain natriuretic peptides: Hormones secreted from the heart.心房利钠肽和脑利钠肽：从心脏分泌的激素。
Peptides. 2019 Jan;111:18-25. doi: 10.1016/j.peptides.2018.05.012. Epub 2018 May 31.
9
Cardiac troponin and outcome in acute heart failure.急性心力衰竭时的心肌肌钙蛋白与预后
N Engl J Med. 2008 May 15;358(20):2117-26. doi: 10.1056/NEJMoa0706824.
10
Cardiac troponins.心肌肌钙蛋白
J Emerg Med. 2002 Jul;23(1):57-65. doi: 10.1016/s0736-4679(02)00463-8.
Zotero 插件